Total Payments
$7,308
2024 Payments
$3,023
Companies
17
Transactions
54
Medicare Patients
6,063
Medicare Billing
$569,684
Payment Breakdown by Category
Education$6,000 (82.1%)
Food & Beverage$1,186 (16.2%)
Other$122.22 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $6,000 | 2 | 82.1% |
| Food and Beverage | $1,186 | 51 | 16.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $122.22 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $6,137 | 5 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $208.23 | 15 | $0 (2017) |
| Astellas Pharma US Inc | $190.98 | 9 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $138.75 | 3 | $0 (2017) |
| United Therapeutics Corporation | $122.22 | 1 | $0 (2018) |
| Respiratory Technologies, Inc. | $81.23 | 4 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $73.90 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $72.70 | 4 | $0 (2017) |
| Veran Medical Technologies, Inc. | $67.07 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $50.66 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,023 | 2 | INTUITIVE SURGICAL, INC. ($3,023) |
| 2023 | $3,134 | 4 | Intuitive Surgical, Inc. ($3,114) |
| 2022 | $47.31 | 1 | KARL STORZ Endoscopy-America ($47.31) |
| 2021 | $27.66 | 2 | JAZZ PHARMACEUTICALS INC. ($14.84) |
| 2019 | $141.82 | 5 | Veran Medical Technologies, Inc. ($67.07) |
| 2018 | $250.96 | 7 | United Therapeutics Corporation ($122.22) |
| 2017 | $683.29 | 33 | Sunovion Pharmaceuticals Inc. ($208.23) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: SURGERY | ||||||
| 01/10/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 12/14/2023 | Intuitive Surgical, Inc. | ION (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 12/14/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: SURGERY | ||||||
| 10/03/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $97.76 | General |
| Category: SURGERY | ||||||
| 03/21/2023 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| Category: Sleep Apnea testing | ||||||
| 05/10/2022 | KARL STORZ Endoscopy-America | C-MAC (Device) | Food and Beverage | In-kind items and services | $47.31 | General |
| Category: ANESTHESIOLOGY | ||||||
| 12/02/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Oncology | ||||||
| 08/05/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug), VYXEOS | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/11/2019 | Fisher & Paykel Healthcare Inc | Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Respiratory | ||||||
| 08/28/2019 | Veran Medical Technologies, Inc. | Spin (Device) | Food and Beverage | Cash or cash equivalent | $67.07 | General |
| Category: Pulmonology | ||||||
| 04/25/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiology | ||||||
| 02/01/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Cardiology | ||||||
| 01/18/2019 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/23/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/10/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/25/2018 | United Therapeutics Corporation | ORENITRAM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $122.22 | General |
| Category: PAH | ||||||
| 06/22/2018 | Astellas Pharma US Inc | MYCAMINE (Drug), CRESEMBA | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/20/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/16/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/16/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $118.14 | General |
| Category: Cardio-pulmonary | ||||||
| 07/19/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $73.90 | General |
| Category: ONCOLOGY | ||||||
| 06/28/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2017 | Respiratory Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: Airway Clearance Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,334 | 1,710 | $384,365 | $116,020 |
| 2022 | 15 | 1,402 | 1,833 | $329,373 | $112,678 |
| 2021 | 21 | 1,847 | 2,455 | $488,678 | $173,814 |
| 2020 | 21 | 1,480 | 2,001 | $485,302 | $167,173 |
Total Patients
6,063
Total Services
7,999
Medicare Billing
$569,684
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 136 | 252 | $50,470 | $22,604 | 44.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 76 | 132 | $66,660 | $20,603 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 193 | $40,985 | $16,352 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 210 | $31,734 | $13,125 | 41.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 67 | $24,455 | $8,682 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $18,018 | $7,163 | 39.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 133 | 144 | $21,564 | $5,224 | 24.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 76 | $11,400 | $4,640 | 40.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 230 | 283 | $26,941 | $4,587 | 17.0% |
| 99183 | Management of oxygen chamber therapy | Facility | 2023 | 11 | 45 | $24,975 | $3,398 | 13.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $7,350 | $3,006 | 40.9% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 11 | 11 | $31,471 | $2,008 | 6.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 61 | 61 | $7,364 | $1,841 | 25.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 14 | $2,835 | $1,152 | 40.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 27 | 27 | $4,335 | $705.42 | 16.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 15 | 15 | $10,575 | $617.81 | 5.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 12 | 12 | $2,040 | $111.12 | 5.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 12 | 12 | $456.00 | $109.92 | 24.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 13 | 13 | $611.00 | $88.01 | 14.4% |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | Office | 2023 | 14 | 42 | $126.00 | $1.49 | 1.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 182 | 314 | $62,800 | $24,410 | 38.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 76 | 111 | $55,485 | $17,789 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 153 | 196 | $38,894 | $16,388 | 42.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 89 | 90 | $32,020 | $13,557 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 190 | $26,912 | $11,146 | 41.4% |
About Dr. Daniel Dodge, DO
Dr. Daniel Dodge, DO is a Internal Medicine healthcare provider based in West Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1124466032.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Dodge, DO has received a total of $7,308 in payments from pharmaceutical and medical device companies, with $3,023 received in 2024. These payments were reported across 54 transactions from 17 companies. The most common payment nature is "Education" ($6,000).
As a Medicare-enrolled provider, Dodge has provided services to 6,063 Medicare beneficiaries, totaling 7,999 services with total Medicare billing of $569,684. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location West Des Moines, IA
- Active Since 06/13/2013
- Last Updated 12/20/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124466032
Products in Payments
- Da Vinci Surgical System (Device) $3,137
- ION (Device) $3,000
- BROVANA (Drug) $196.56
- Adempas (Drug) $138.75
- ORENITRAM (Drug) $122.22
- CRESEMBA (Drug) $110.86
- OFEV (Drug) $73.90
- Spin (Device) $67.07
- Cresemba (Drug) $59.40
- ANORO (Drug) $57.21
- C-MAC (Device) $47.31
- UPTRAVI (Drug) $38.60
- ZERBAXA (Drug) $35.08
- MYCAMINE (Drug) $20.72
- WatchPATONE (Device) $20.34
- ORBACTIV (Drug) $15.98
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $15.75
- BREO (Drug) $15.49
- ZEPZELCA (Drug) $14.84
- LUMAKRAS (Drug) $12.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Des Moines
Dr. Dustin Mccann, Do, DO
Internal Medicine — Payments: $59,412
Internal Medicine $59,412
Dwayne Campbell, M.d, M.D
Internal Medicine — Payments: $39,818
Internal Medicine $39,818
Dr. Vuong Nayima, Do, DO
Internal Medicine — Payments: $33,048
Internal Medicine $33,048
Dr. Fadi Alkhatib, Do, DO
Internal Medicine — Payments: $13,263
Internal Medicine $13,263
Samantha Danielson-Jones, M.d, M.D
Internal Medicine — Payments: $11,382
Internal Medicine $11,382
Dr. Ryan Mertens, Do, DO
Internal Medicine — Payments: $5,771
Internal Medicine $5,771